David Zheng, FNP-BC
NPI 1457063943 · Family Nurse Practitioner · Arlington, VA
Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1457063943
- Entity type
- Individual
- Primary specialty
- Family Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- FNP-BC
- Sex
- Male
- Sole proprietor
- No
- License
- 0024185957 (VA)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
3 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,004 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 576 | $119 |
| Automated Urinalysis Test81003 | 161 | $2 |
| Insertion of Lower Leg Neurostimulator Electrode64566 | 135 | $112 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 73 | $157 |
| Instillation of Anti-Cancer Drug Into Bladder51720 | 41 | $85 |
| Administration of Hormonal Anti-Neoplastic Chemotherapy Under Skin Or Into Muscle96402 | 18 | $34 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 15 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Tamsulosin Hcl | 252 | 98 |
| Finasteride | 166 | 57 |
| Methenamine Hippurate | 74 | 18 |
| Alfuzosin Hclbrand: Alfuzosin Hcl Er | 57 | 20 |
| Vibegronbrand: Gemtesa | 46 | 20 |
| Mirabegronbrand: Myrbetriq | 41 | 14 |
| Nitrofurantoin Monohyd/M-Crystbrand: Nitrofurantoin Mono-Macro |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$726 across 40 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2022-12-16
- Last updated
- 2022-12-16
- Certified
- 2022-12-16
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.